RIGL
NASDAQ · Biotechnology
Rigel Pharmaceuticals Inc
$46.64
+0.79 (+1.72%)
Open$45.54
Previous Close$45.85
Day High$46.99
Day Low$45.24
52W High$52.24
52W Low$24.95
Volume—
Avg Volume203.7K
Market Cap856.47M
P/E Ratio2.66
EPS$16.04
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+16.0% upside
Current
$46.64
$46.64
Target
$54.10
$54.10
$39.68
$54.10 avg
$74.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 292.42M | 216.96M | 385.25M |
| Net Income | 364.70M | 243.53M | -63,461,041 |
| Profit Margin | 124.7% | 118.5% | -16.5% |
| EBITDA | 127.07M | 89.57M | -108,813,206 |
| Free Cash Flow | — | — | -71,858,369 |
| Rev Growth | +34.8% | +34.8% | +12.7% |
| Debt/Equity | 0.13 | 0.13 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |